Literature DB >> 20587378

New clinical features of thyroid cancer in eastern China.

J Xiang1, Y Wu, D S Li, Q Shen, Z Y Wang, T Q Sun, Y An, Q Guan.   

Abstract

OBJECTIVE: Analyze recent clinical features of thyroid cancer in eastern China.
METHODS: Investigation and comparison of clinical data of thyroid cancer patients from 1996 to 2006 from the Department of Head and Neck Surgery in the Cancer Hospital of Fudan University, Shanghai, China.
RESULTS: The number of patients with thyroid cancer rose from 148 in the year 1996 to 572 in the year 2006, a 3.9-fold increase. Routine ultrasound survey during physical examination revealed four cases (2.7%) in 1996 and 285 cases (49.8%) in 2006. The sensitivity of the ultrasound survey in thyroid cancer diagnosis was 86.66% in 1996 and 88.20% in 2006 (P>0.05). Papillary carcinoma was most prevalent (87.8% in 1996 and 92.8% in 2006). An increasing proportion of small tumors was found. The incidence of microcarcinoma was 35.7% in 2006 in contrast with 20.3% in 1996 (P<0.01). Moreover, tumors with diameter from 1 to 2 cm were found in 38.5% patients in 2006 as opposed to 27.0% in 1996 (P<0.01). Extrathyroid extension was reported in 46 (31.1%) patients in 1996, but only in 39 (6.8%) in 2006 (P<0.01). Central cervical lymph node metastases were found in 98 (66.2%) patients in 1996, contrasting with 301 (52.6%) in 2006 (P<0.05). Thirty-seven (25.0%) patients had lateral cervical lymph node metastasis in 1996 compared with 117 (20.5%) in 2006 (P>0.05). Last, the proportion of stage I cancers in 2006 was higher than that in 1996.
CONCLUSION: With the increasing incidence of thyroid cancer, cancer was discovered at an earlier stage. This is due to new clinical features of thyroid cancer, such as the decrease in tumor diameter, the lower rate of extrathyroid extension and of cervical lymph node metastasis. Routine ultrasound survey during physical examination has become the most common way to detect thyroid cancer. Increasing usage of diagnostic scrutiny, including the ultrasound survey, has most likely contributed to the increased incidence through detection of small thyroid cancers. Increased use of ultrasound to screen thyroid cancer in early stages should lead to better therapeutic outcome. (c) 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20587378     DOI: 10.1016/j.jviscsurg.2010.02.007

Source DB:  PubMed          Journal:  J Visc Surg        ISSN: 1878-7886            Impact factor:   2.043


  17 in total

1.  Correlation between body mass index and clinicopathological features of papillary thyroid microcarcinoma.

Authors:  Zeming Liu; Yusufu Maimaiti; Pan Yu; Yiquan Xiong; Wen Zeng; Xiaoyu Li; Haiping Song; Chong Lu; Yue Xin; Jing Zhou; Ning Zhang; Jie Ming; Chunping Liu; Wei Shi; Lan Shi; Xueqin Li; Xiu Nie; Tao Huang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  Prediction of central lymph node metastasis in 392 patients with cervical lymph node-negative papillary thyroid carcinoma in Eastern China.

Authors:  Yingying Xiang; Kuailu Lin; Siyang Dong; L I Qiao; Qiuxiang He; Xiaohua Zhang
Journal:  Oncol Lett       Date:  2015-07-29       Impact factor: 2.967

3.  Predicting the factors of lateral lymph node metastasis in papillary microcarcinoma of the thyroid in eastern China.

Authors:  Rui-chao Zeng; Quan Li; Kuai-lu Lin; Wei Zhang; Er-li Gao; Guan-li Huang; Xiao-hua Zhang; Min-hua Zheng
Journal:  Clin Transl Oncol       Date:  2012-08-08       Impact factor: 3.405

4.  Prognostic evaluation model for papillary thyroid cancer: a retrospective study of 660 cases.

Authors:  Yi-Ming Cao; Ting-Ting Zhang; Bao-Yuan Li; Ning Qu; Yong-Xue Zhu
Journal:  Gland Surg       Date:  2021-07

5.  Efficacy of apparent diffusion coefficient in predicting aggressive histological features of papillary thyroid carcinoma.

Authors:  Bin Song; Hao Wang; Yongqi Chen; Weiyan Liu; Ran Wei; Yi Ding
Journal:  Diagn Interv Radiol       Date:  2018-11       Impact factor: 2.630

6.  Risk factors for central lymph node metastasis of patients with papillary thyroid microcarcinoma: a meta-analysis.

Authors:  Zeming Liu; Longqiang Wang; Pengfei Yi; Cong-Yi Wang; Tao Huang
Journal:  Int J Clin Exp Pathol       Date:  2014-02-15

7.  Increasing thyroid cancer rate and the extent of thyroid surgery in Korea.

Authors:  Myung-Whun Sung; Bumjung Park; Soo-Youn An; J Hun Hah; Young Ho Jung; Hyo Geun Choi
Journal:  PLoS One       Date:  2014-12-03       Impact factor: 3.240

8.  Coexistence of Histologically Confirmed Hashimoto's Thyroiditis with Different Stages of Papillary Thyroid Carcinoma in a Consecutive Chinese Cohort.

Authors:  Xiaoyun Liu; Lijun Zhu; Dai Cui; Zhixiao Wang; Huanhuan Chen; Yu Duan; Meiping Shen; Yunsong Wu; Rong Rong; Zhihong Zhang; Xiaodong Wang; Jiawei Chen; Erik K Alexander; Tao Yang
Journal:  Int J Endocrinol       Date:  2014-11-18       Impact factor: 3.257

9.  Clinicopathological implications of leptin and leptin receptor expression in papillary thyroid cancer.

Authors:  Guo-An Zhang; Sen Hou; Sha Han; Jian Zhou; Xu Wang; Wen Cui
Journal:  Oncol Lett       Date:  2013-01-10       Impact factor: 2.967

10.  Reevaluating the prognostic significance of male gender for papillary thyroid carcinoma and microcarcinoma: a SEER database analysis.

Authors:  Chunping Liu; Tianwen Chen; Wen Zeng; Shuntao Wang; Yiquan Xiong; Zeming Liu; Tao Huang
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.